Insider selling
Traded Mar 6, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Abbott Laboratories's AND GROUP PRESIDENT sold $12.2M of Abbott Laboratories shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
63 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q3 2024 13F
383,059
369,886
−3.4%
Share count drives classification; reported value also moves with price
0.29%
Within the filing's reported positions, not the manager's total assets
63
For Q4 2024
Insider selling
Traded Mar 6, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Abbott Laboratories's AND GROUP PRESIDENT sold $12.2M of Abbott Laboratories shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Mar 7, 2025 · filed the same dayNot reported under a pre-arranged trading plan
Abbott Laboratories's AND GROUP PRESIDENT sold $27K of Abbott Laboratories shares. The filing does not indicate a pre-arranged trading plan.
Congress
Traded Feb 13, 2025 · disclosed 21 days laterJoint
7 different filers disclosed ABT within 90 days.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.